{"id":"https://openalex.org/W1997107220","doi":"https://doi.org/10.1002/j.1552-4604.1992.tb03823.x","title":"Comparison of Verapamil, Diltiazem, and Labetalol on the Bioavailability and Metabolism of Imipramine","display_name":"Comparison of Verapamil, Diltiazem, and Labetalol on the Bioavailability and Metabolism of Imipramine","publication_year":1992,"publication_date":"1992-02-01","ids":{"openalex":"https://openalex.org/W1997107220","doi":"https://doi.org/10.1002/j.1552-4604.1992.tb03823.x","mag":"1997107220","pmid":"https://pubmed.ncbi.nlm.nih.gov/1613128"},"language":"en","primary_location":{"id":"doi:10.1002/j.1552-4604.1992.tb03823.x","doi":"https://doi.org/10.1002/j.1552-4604.1992.tb03823.x","is_oa":false,"landing_page_url":"https://doi.org/10.1002/j.1552-4604.1992.tb03823.x","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103999908","display_name":"David J. Hermann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J. Hermann","raw_affiliation_strings":["Drug Development Laboratory, University of North Carolina, School of Pharmacy, Chapel Hill 27599-7360","Drug Development Laboratory, University of North Carolina, Schools of Pharmacy and Medicine, Chapel Hill, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Laboratory, University of North Carolina, School of Pharmacy, Chapel Hill 27599-7360","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Drug Development Laboratory, University of North Carolina, Schools of Pharmacy and Medicine, Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010042815","display_name":"Thomas F. Krol","orcid":"https://orcid.org/0000-0003-0086-5904","observed_orcids":["https://orcid.org/0000-0003-0086-5904"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas F. Krol","raw_affiliation_strings":["Drug Development Laboratory, University of North Carolina, Schools of Pharmacy and Medicine, Chapel Hill, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Laboratory, University of North Carolina, Schools of Pharmacy and Medicine, Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060601295","display_name":"George Earl Dukes","orcid":"https://orcid.org/0009-0007-3404-860X","observed_orcids":["https://orcid.org/0009-0007-3404-860X"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"George E. Dukes","raw_affiliation_strings":["Drug Development Laboratory, University of North Carolina, Schools of Pharmacy and Medicine, Chapel Hill, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Laboratory, University of North Carolina, Schools of Pharmacy and Medicine, Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112516696","display_name":"Elizabeth K. Hussey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth K. Hussey","raw_affiliation_strings":["Drug Development Laboratory, University of North Carolina, Schools of Pharmacy and Medicine, Chapel Hill, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Laboratory, University of North Carolina, Schools of Pharmacy and Medicine, Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008883559","display_name":"Marion Danis","orcid":"https://orcid.org/0000-0002-4749-4568","observed_orcids":["https://orcid.org/0000-0002-4749-4568"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marion Danis","raw_affiliation_strings":["Drug Development Laboratory, University of North Carolina, Schools of Pharmacy and Medicine, Chapel Hill, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Laboratory, University of North Carolina, Schools of Pharmacy and Medicine, Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100294712","display_name":"Yiang\u2010Hau Han","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yiang\u2010Hau Han","raw_affiliation_strings":["Drug Development Laboratory, University of North Carolina, Schools of Pharmacy and Medicine, Chapel Hill, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Laboratory, University of North Carolina, Schools of Pharmacy and Medicine, Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052392053","display_name":"J. Robert Powell","orcid":"https://orcid.org/0000-0003-2341-6239","observed_orcids":["https://orcid.org/0000-0003-2341-6239"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Robert Powell","raw_affiliation_strings":["Drug Development Laboratory, University of North Carolina, Schools of Pharmacy and Medicine, Chapel Hill, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Laboratory, University of North Carolina, Schools of Pharmacy and Medicine, Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112870486","display_name":"Lawrence J. Hak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence J. Hak","raw_affiliation_strings":["Drug Development Laboratory, University of North Carolina, Schools of Pharmacy and Medicine, Chapel Hill, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Laboratory, University of North Carolina, Schools of Pharmacy and Medicine, Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5060601295"],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":1.7249,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.82238152,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"32","issue":"2","first_page":"176","last_page":"183"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imipramine","display_name":"imipramine","score":0.9829999804496765},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.9700000286102295},{"id":"https://openalex.org/keywords/diltiazem","display_name":"diltiazem","score":1.0},{"id":"https://openalex.org/keywords/labetalol","display_name":"labetalol","score":1.0},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.8830000162124634},{"id":"https://openalex.org/keywords/relative-bioavailability","display_name":"relative bioavailability","score":0.8059999942779541},{"id":"https://openalex.org/keywords/desipramine","display_name":"desipramine","score":0.9779999852180481},{"id":"https://openalex.org/keywords/enzyme-inhibition","display_name":"enzyme inhibition","score":0.6949999928474426},{"id":"https://openalex.org/keywords/oral-clearance","display_name":"oral clearance","score":0.871999979019165},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.9089999794960022}],"concepts":[{"id":"https://openalex.org/C2777962398","wikidata":"https://www.wikidata.org/wiki/Q958087","display_name":"Labetalol","level":3,"score":0.8975251913070679},{"id":"https://openalex.org/C2776741139","wikidata":"https://www.wikidata.org/wiki/Q422229","display_name":"Diltiazem","level":3,"score":0.8882701396942139},{"id":"https://openalex.org/C2779145073","wikidata":"https://www.wikidata.org/wiki/Q58396","display_name":"Imipramine","level":3,"score":0.8493751287460327},{"id":"https://openalex.org/C2777022698","wikidata":"https://www.wikidata.org/wiki/Q410291","display_name":"Verapamil","level":3,"score":0.7661631107330322},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6742530465126038},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6405938863754272},{"id":"https://openalex.org/C2780250439","wikidata":"https://www.wikidata.org/wiki/Q423288","display_name":"Desipramine","level":4,"score":0.5613752007484436},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5474229454994202},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5253400206565857},{"id":"https://openalex.org/C2776256041","wikidata":"https://www.wikidata.org/wiki/Q424952","display_name":"Nadolol","level":3,"score":0.5066435933113098},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.48112431168556213},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.4518985450267792},{"id":"https://openalex.org/C2776525901","wikidata":"https://www.wikidata.org/wiki/Q411325","display_name":"Atenolol","level":3,"score":0.4426308572292328},{"id":"https://openalex.org/C2779066535","wikidata":"https://www.wikidata.org/wiki/Q39111","display_name":"Nifedipine","level":3,"score":0.43040427565574646},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4217595160007477},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36555445194244385},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3336573839187622},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32862770557403564},{"id":"https://openalex.org/C2778151854","wikidata":"https://www.wikidata.org/wiki/Q423364","display_name":"Propranolol","level":2,"score":0.245443195104599},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.22595006227493286},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.0930054783821106},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003891","descriptor_name":"Desipramine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D003891","descriptor_name":"Desipramine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004110","descriptor_name":"Diltiazem","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D007741","descriptor_name":"Labetalol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/j.1552-4604.1992.tb03823.x","doi":"https://doi.org/10.1002/j.1552-4604.1992.tb03823.x","is_oa":false,"landing_page_url":"https://doi.org/10.1002/j.1552-4604.1992.tb03823.x","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:1613128","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1613128","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical pharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.7599999904632568,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G251702431","display_name":null,"funder_award_id":"RR00046","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G4137263475","display_name":"General Clinical Research Center","funder_award_id":"M01RR000046","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"}],"funders":[{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1979194952","https://openalex.org/W1983808158","https://openalex.org/W1985475479","https://openalex.org/W1988973970","https://openalex.org/W1998481335","https://openalex.org/W2002756018","https://openalex.org/W2011910735","https://openalex.org/W2022667643","https://openalex.org/W2036554267","https://openalex.org/W2048393977","https://openalex.org/W2056196711","https://openalex.org/W2058614622","https://openalex.org/W2079891338","https://openalex.org/W2092562160","https://openalex.org/W2112459643","https://openalex.org/W2128986157","https://openalex.org/W2140975948","https://openalex.org/W2143552613","https://openalex.org/W2165431694","https://openalex.org/W2410779580","https://openalex.org/W4248816661"],"related_works":["https://openalex.org/W2098894517","https://openalex.org/W2409237059","https://openalex.org/W2106038521","https://openalex.org/W2003143887","https://openalex.org/W2134768052","https://openalex.org/W2044722026","https://openalex.org/W2036554267","https://openalex.org/W2048502024","https://openalex.org/W1985355428","https://openalex.org/W2417027909"],"abstract_inverted_index":{"Twelve":[0],"healthy":[1],"male":[2],"subjects":[3],"completed":[4],"this":[5,209],"randomized,":[6],"placebo":[7,57,122],"controlled,":[8],"four-period":[9],"crossover":[10],"trial":[11],"to":[12,155,163,178,229],"determine":[13],"the":[14,22,72,89,112,138,141,150,179,192,202,219,235],"effect":[15],"of":[16,26,33,35,74,77,140,152,171,174,205,213,222],"verapamil,":[17],"diltiazem,":[18,105],"and":[19,24,82,102,106,126,130,160,176,233],"labetalol":[20,50,107,200],"on":[21,71,191],"bioavailability":[23],"metabolism":[25],"imipramine.":[27,223],"Subjects":[28],"received":[29],"a":[30,146],"7-day":[31],"course":[32],"one":[34],"four":[36],"treatments;":[37],"verapamil":[38],"(120":[39],"mg":[40,46,52],"every":[41,47,53],"8":[42,48],"hr),":[43,49,55],"diltiazem":[44,131],"(90":[45],"(200":[51],"12":[54,59],"or":[56],"(every":[58],"hr)":[60],"during":[61],"each":[62,78],"study":[63,79],"period.":[64,80],"Imipramine":[65],"(100":[66],"mg)":[67],"was":[68],"administered":[69],"orally":[70],"morning":[73],"day":[75],"4":[76],"Plasma":[81],"urine":[83],"samples":[84],"were":[85,94,182],"collected":[86],"periodically":[87],"over":[88],"ensuing":[90],"96":[91],"hours.":[92],"Samples":[93],"assayed":[95],"by":[96,123,207],"HPLC":[97],"for":[98,237],"imipramine,":[99],"desipramine,":[100],"2-hydroxyimipramine,":[101],"2-hydroxydesipramine.":[103],"Verapamil,":[104],"increased":[108],"imipramine":[109,153,206,231],"area":[110],"under":[111],"plasma":[113,172],"concentration":[114],"time":[115],"curve":[116],"(relative":[117],"bioavailability)":[118],"as":[119],"compared":[120],"with":[121],"15%,":[124],"30%,":[125],"53%,":[127],"respectively.":[128],"Verapamil":[129],"did":[132],"not":[133],"demonstrate":[134],"consistent":[135],"changes":[136],"in":[137,149],"formation":[139],"measured":[142],"metabolites.":[143],"Labetalol":[144],"caused":[145],"significant":[147],"decrease":[148],"amount":[151],"metabolized":[154],"2-hydroxyimipramine":[156,175],"(mean":[157,165],"decrease:":[158,166],"22%)":[159],"from":[161],"desipramine":[162],"2-hydroxydesipramine":[164,177],"8%).":[167],"The":[168],"molar":[169],"ratios":[170],"AUC":[173],"parent":[180],"compounds":[181],"significantly":[183],"decreased.":[184],"Since":[185],"these":[186,196,214],"metabolic":[187],"processes":[188],"are":[189],"dependent":[190],"cytochrome":[193],"P450IID6":[194],"isozyme,":[195],"data":[197],"suggest":[198],"that":[199],"decreases":[201],"oral":[203,220],"clearance":[204,221],"inhibiting":[208],"system.":[210],"All":[211],"three":[212],"commonly":[215],"used":[216],"agents":[217],"decreased":[218],"These":[224],"drug":[225],"interactions":[226],"could":[227],"lead":[228],"elevated":[230],"concentrations":[232],"have":[234],"potential":[236],"clinically":[238],"important":[239],"adverse":[240],"events.":[241]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}